SC 13D Filing

Company

ABVC BIOPHARMA, INC.

Filed

November 16, 2009

Accession Number

0001140361-09-026158

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →